QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
CVE:MED

Medgold Resources (MED) Stock Price, News & Analysis

C$0.0050
-0.01 (-50.00%)
(As of 11/22/2022)
Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.03
Volume
4,800 shs
Average Volume
131,112 shs
Market Capitalization
C$673,950.00
P/E Ratio
N/A
Dividend Yield
38,400.00%
Price Target
N/A

About Medgold Resources

Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of precious metal properties in Europe. The company explores for gold, silver, copper, lead, and zinc deposits. It holds a 100% interest in the Tlamino project comprising three exploration licenses, such as Donje Tlamino and Surlica-Dukat covering an area of 192 square kilometers located in the far southeast of Serbia. The company was incorporated in 1966 and is headquartered in Vancouver, Canada.

MED Stock Price History

MED Stock News Headlines

Medgold Resources Corp (MED)
See More Headlines
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medgold Resources and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
4/23/2024

Industry, Sector and Symbol

Industry
Other Precious Metals & Mining
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
713
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$673,950.00
Optionable
Not Optionable
Beta
0.61
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Jeremy Crozier
    President, CEO & Director
  • Mr. Kevin Bales (Age 57)
    Chief Financial Officer
    Comp: $29.25k
  • Mr. Brett A. Kagetsu B.Comm (Age 54)
    Esq., LLB, Corporate Secretary
  • Mr. Brent Cook BSc (Geology)
    Technical Advisor

MED Stock Analysis - Frequently Asked Questions

How have MED shares performed in 2024?

Medgold Resources' stock was trading at C$0.01 at the beginning of the year. Since then, MED stock has increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2024 here
.

When is Medgold Resources' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our MED earnings forecast
.

Is Medgold Resources a good dividend stock?

Medgold Resources (CVE:MED) pays an annual dividend of C$1.92 per share and currently has a dividend yield of 14.04%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

What other stocks do shareholders of Medgold Resources own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medgold Resources investors own include Nevsun Resources (NSU) and

How do I buy shares of Medgold Resources?

Shares of MED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:MED) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners